Our new Cryptocurrency section has arrived! Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCello Health Regulatory News (CLL)

Share Price Information for Cello Health (CLL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 128.50
Bid: 127.00
Ask: 130.00
Change: 1.50 (1.18%)
Spread: 3.00 (2.36%)
Open: 127.00
High: 129.00
Low: 127.00
Yest. Close: 127.00
CLL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Total Voting Rights

Tue, 3rd Dec 2019 15:09

RNS Number : 5474V
Cello Health PLC
03 December 2019
 

3 December 2019

 

Cello Health plc

("Cello" or the "Company")

 

Total Voting Rights

 

As at 2 December 2019, Cello's issued share capital comprises 106,683,196 ordinary shares of 10 pence each ("Ordinary Shares"), of which 453,000 Ordinary Shares are held in treasury. The total number of current voting rights in the Company is therefore 106,230,196 Ordinary Shares.

 

The above figure (106,230,196 Ordinary Shares) may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

Enquiries:

 

Cello Health plc

020 7812 8460

Mark Scott, Chief Executive


Mark Bentley, Group Finance Director

www.cellohealthplc.com




Cenkos Securities plc

020 7397 8900

Giles Balleny


Harry Hargreaves




Buchanan

Mark Court

020 7466 5000

Jamie Hooper


Sophie Wills


 

 


About Cello Health plc

Cello Health plc is a global healthcare-focused advisory Group comprised of a set of leading clinical, commercial advisory and digital delivery capabilities. Cello Health plc currently services 24 of the top 25 pharmaceutical clients globally, as well as a wide range of biotech, diagnostics, devices and other key non-healthcare clients.

Cello Health plc enables clients to commercialise, differentiate their assets, and drive brand success in ever more complex global markets. The business delivers its services through nearly 1,000 highly skilled professionals, utilising latest thinking, technology and digital solutions.

Cello Health plc delivers its services from an office network in the UK, USA, and Asia, with hub offices in New York City, Philadelphia PA, London, Edinburgh, Farnham and Cheltenham.

For further information, please visit: https://cellohealthplc.com


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVREXLFBKLFBFBD
Date   Source Headline
3rd Dec 20193:09 pmRNSTotal Voting Rights
22nd Nov 20194:55 pmRNSHolding(s) in Company
14th Nov 20199:30 amRNSHolding(s) in Company
13th Nov 20195:00 pmRNSTotal Voting Rights
7th Oct 20191:39 pmRNSHolding(s) in Company

Login to your account

Don't have an account? Click here to register.